AUA MA 2009 - Relationship between the PCA3 molecular urine test and prostate biopsy results in an active surveillance program - Session Highlights
WILLIAMSBURG, VA, USA (UroToday.com) - This study from Johns Hopkins assessed the ability of Prostate Cancer Gene 3 (PCA3) to predict progression in men in an active surveillance program.
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
